Secondary leukemia (sL) after multiple high-dose chemotherapy (HDCT) with peripheral blood stem cells (PBSC) reinfusion for high risk breast cancer (HRBC) patients (pts)

被引：0
|
作者：
Cinieri, S [1 ]
Cocorocchio, E [1 ]
Ferrucci, PF [1 ]
Peccatori, FA [1 ]
Rabascio, C [1 ]
Alietti, A [1 ]
Laszlo, D [1 ]
Giordano, G [1 ]
Agazzi, A [1 ]
Pastano, R [1 ]
Vanazzi, A [1 ]
Bertolini, F [1 ]
Pruneri, G [1 ]
Goldhirsch, A [1 ]
Martinelli, G [1 ]
机构：
[1] European Inst Oncol, Dept Internal Med, Hematoncol Div, Milan, Italy
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3645
引用
收藏
页码：979A / 979A
页数：1
相关论文
共 50 条
  • [1] Multiple high dose chemotherapy with peripheral blood stem cells (PBSC) reinfusion in high risk breast cancer
    Cocorocchio, E
    Peccatori, F
    Zimatore, M
    Ferrucci, PF
    Cinieri, S
    Agazzi, A
    Martinelli, G
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 9 - 9
  • [2] Preliminary results of high-dose chemotherapy (HDCT) with peripheral blood stem cell (PBSC) support in patients with breast cancer.
    Zmatchinski, V
    Uss, A
    Milanovich, N
    Skrahin, A
    Dzuba, E
    Mitskevich, O
    Zavgorodniay, I
    Batan, Z
    Vinogradov, V
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S193 - S193
  • [3] Double high-dose chemotherapy (HDCT) with peripheral blood stem cell transplantation (PBSC) in patients with metastatic breast cancer and high grade lymphoma
    Bojko, P
    Kloster, G
    Weidmann, B
    Gaczkowski, A
    Halbe, J
    Niederle, N
    [J]. BLOOD, 1995, 86 (10) : 3739 - 3739
  • [4] Phase II study of leridistim in breast cancer patients following high dose chemotherapy (HDCT) and autologous peripheral blood stem cell (PBSC) reinfusion.
    Weinberger, B
    Reece, D
    Schuster, M
    Herzig, R
    Jansen, J
    Lynch, J
    Miller, A
    Tutschka, P
    Needle, MN
    Baum, CM
    [J]. BLOOD, 1999, 94 (10) : 49A - 49A
  • [5] Phase I study of high-dose chemotherapy with peripheral blood stem-cells reinfusion (PBSC) in patients with metastatic or inflammatory breast cancer (MBC).
    Fabbro, M
    Thezenas, S
    Wandzel, S
    Kramar, A
    Martinez, A
    Mir, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 63S - 63S
  • [6] HIGH-DOSE CHEMOTHERAPY (HDCT), PERIPHERAL BLOOD PROGENITOR CELL TRANSPLANTATION (PBPCT) AND IMMUNOTHERAPY IN THE TREATMENT OF HIGH-RISK EARLY BREAST CANCER (HRBC)
    Recchia, F.
    Candeloro, G.
    Sureda, M.
    Necozione, S.
    Rea, S.
    Brugarolas, A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 87 - 87
  • [7] Multiple high-dose chemotherapy with peripheral blood stem cells in high risk breast cancer patients is safe and feasible.
    Cinieri, S
    Ferrucci, PF
    Cocorocchlo, E
    Peccatori, F
    El Taani, H
    Zimatore, M
    Martinelli, G
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S38 - S38
  • [8] High-dose chemotherapy (HDC) with peripheral blood stem cells (PBSC) in the treatment of inflammatory breast cancer (IBC)
    Aieta, M.
    D'Addetta, C.
    Latiano, T. P.
    Palomba, G.
    Maiello, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII142 - VII142
  • [9] Sequential high-dose chemotherapy with peripheral blood stem cell (PBSC) support as adjuvant therapy for patients with high-risk breast cancer.
    Hohaus, S
    Wallwiener, D
    Schneeweiss, A
    Egerer, G
    Martin, S
    Abdallah, A
    Goldschmidt, H
    Fersis, N
    Bastert, G
    Haas, R
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 : S93 - S94
  • [10] Radiotherapy after high-dose chemotherapy and peripheral blood stem cell support in high-risk breast cancer
    Hoeller, U
    Heide, J
    Kroeger, N
    Krueger, W
    Jaenicke, F
    Alberti, W
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (05): : 1234 - 1239
12345